Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Fernandes

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nephrologie & Therapeutique|March 10, 2026
Iodinated and gadolinium-based contrast agents in patients with chronic kidney disease: A review of international guidelines (SFNDT/SFR, ESUR, ACR/NKF, CAR)Catherine Verhellen, Maxime Beringuier, Laura Labriola, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 19, 2026
Impact of peritoneal dialysis fluid composition and infusion timing on 18F-fluoro-2-deoxy-2-d-glucose positron emission tomography-computed tomography interpretability in peritoneal dialysis patientsGuillaume Fernandes, Michael Moryoussef, Inès Dufour, et al.
Kidney International|December 25, 2025
Meta-organismal tryptophan metabolism: an appealing therapeutic target in CKD-MBDGuillaume Fernandes, Stéphane Burtey, Ward Zadora, et al.
Journal of Clinical Medicine|October 26, 2024
Basiliximab vs. No Induction Therapy in Kidney Transplant Recipients with a Low Immunological Risk Profile Receiving Tacrolimus/Mycophenolate/Steroids Maintenance ImmunosuppressionFlorian Lacave, Christophe de Terwangne, Tom Darius, et al.
Kidney Medicine|May 2, 2022
Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case SeriesGuillaume Fernandes, Arnaud Devresse, Anais Scohy, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nephrologie & Therapeutique|March 10, 2026
Iodinated and gadolinium-based contrast agents in patients with chronic kidney disease: A review of international guidelines (SFNDT/SFR, ESUR, ACR/NKF, CAR)Catherine Verhellen, Maxime Beringuier, Laura Labriola, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 19, 2026
Impact of peritoneal dialysis fluid composition and infusion timing on 18F-fluoro-2-deoxy-2-d-glucose positron emission tomography-computed tomography interpretability in peritoneal dialysis patientsGuillaume Fernandes, Michael Moryoussef, Inès Dufour, et al.
Kidney International|December 25, 2025
Meta-organismal tryptophan metabolism: an appealing therapeutic target in CKD-MBDGuillaume Fernandes, Stéphane Burtey, Ward Zadora, et al.
Journal of Clinical Medicine|October 26, 2024
Basiliximab vs. No Induction Therapy in Kidney Transplant Recipients with a Low Immunological Risk Profile Receiving Tacrolimus/Mycophenolate/Steroids Maintenance ImmunosuppressionFlorian Lacave, Christophe de Terwangne, Tom Darius, et al.
Kidney Medicine|May 2, 2022
Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case SeriesGuillaume Fernandes, Arnaud Devresse, Anais Scohy, et al.
Pageof 1